Scientific Advisory Board

Scientific Advisory Board

We work with some of the leading minds in medicine and data science to create a new standard for quality measurement. Our Scientific Advisory Board is comprised of physicians and data scientists from the country’s top academic institutions. These leaders provide insight into the latest scientific research, clinical guidelines and quality measures to help Embold identify the factors shown to consistently deliver the best results for patients.

Scientific Advisory Board Co-Chairs


Dr. Matthew Resnick
Chief Medical Officer of Embold Health


Dr. Arnie Milstein
Professor of Medicine at Stanford University

Scientific Advisory Board Members:

Kevin Bozic, MD, MBA
Chair, Department of Surgery and Perioperative Care,
UT Austin Dell Medical School

Doug Blayney, MD
Professor of Medicine,
Stanford University

Daniel Duffy, MD
Professor of Medicine,
University of Oklahoma School of Medicine

Scott Ramsey, MD, PhD
Hutchinson Institute for Cancer Outcomes Research

Dena Bravata, MD
Former CMO,
Castlight Health

Scott Zeger, PhD
Professor of Biostatistics,
Johns Hopkins Bloomberg School of Public Health

Earl Steinberg, MD
Former CEO,
xG Health Solutions,
Former EVP,
Geisinger Health

Michael van Duren, MD, MBA
Clinical Variation Lead,